CERO THERAPEUTICS HLDGS INC (CEROW) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
9:02 pm
Purchase
2025-06-3013GCERo Therapeutics Holdings, Inc.
CERO
Armistice Capital, LLC63,308
4.990%
63,308increase
(New Position)
Filing
History
2025-05-15
3:12 pm
Purchase
2025-03-3113GCERo Therapeutics Holdings, Inc.
CERO
Armistice Capital, LLC29,227
9.990%
29,227increase
(New Position)
Filing
History
2025-04-04
7:17 pm
Purchase
2025-03-3113DCERo Therapeutics Holdings, Inc.
CERO
ATWOOD BRIAN G25,590
9.900%
15,470increase
(+152.86%)
Filing
History
2025-02-07
5:21 pm
Purchase
2025-02-0713DCERo Therapeutics Holdings, Inc.
CERO
ATWOOD BRIAN G10,120
6.700%
254increase
(+2.57%)
Filing
History
2024-12-17
7:26 pm
Sale
2024-12-1313GCERo Therapeutics Holdings, Inc.
CERO
YK Bioventures Opportunities GP I, LLC9
0.000%
-11,302decrease
(-99.92%)
Filing
History
2024-12-13
7:18 pm
Purchase
2024-12-1013GMerida Merger Corp. I
MCMJ
Corey Lawrence8,529,316
5.700%
8,529,316increase
(New Position)
Filing
History
2024-11-20
4:06 pm
Purchase
2024-09-2413GCERo Therapeutics Holdings, Inc.
CERO
SLOAN STUART M10,534
14.000%
10,036increase
(+2013.84%)
Filing
History
2024-11-20
4:01 pm
Purchase
2024-02-1413GCERo Therapeutics Holdings, Inc.
CERO
SLOAN STUART M498
6.700%
498increase
(New Position)
Filing
History
2024-11-14
8:18 pm
Purchase
2024-08-0213GCERo Therapeutics Holdings, Inc.
CERO
YK Bioventures Opportunities GP I, LLC11,310
15.000%
11,310increase
(New Position)
Filing
History
2024-10-30
8:58 pm
Purchase
2024-09-2513DCERo Therapeutics Holdings, Inc.
CERO
ATWOOD BRIAN G9,866
13.400%
9,866increase
(New Position)
Filing
History
2024-02-22
09:06 am
Sale
2023-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Shaolin Capital Management LLC0
0.000%
-374decrease
(Position Closed)
Filing
History
2024-02-20
5:18 pm
Sale
2024-02-1413DCERo Therapeutics Holdings, Inc.
CERO
PHOENIX BIOTECH SPONSOR LLC508
6.800%
-2,141decrease
(-80.84%)
Filing
History
2024-02-08
12:31 pm
Sale
2023-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Saba Capital Management, L.P.0
0.000%
-606decrease
(Position Closed)
Filing
History
2023-02-14
3:45 pm
Unchanged
2022-12-3013GCERo Therapeutics Holdings, Inc.
CERO
GOLDMAN SACHS GROUP INC
GS
0
0.000%
0
(Unchanged)
Filing
History
2023-02-14
1:51 pm
Sale
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Beryl Capital Management LLC0
0.000%
-615decrease
(Position Closed)
Filing
History
2023-02-14
06:39 am
Purchase
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Saba Capital Management, L.P.606
6.600%
128increase
(+26.63%)
Filing
History
2023-02-13
8:05 pm
Purchase
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Shaolin Capital Management LLC374
6.580%
374increase
(New Position)
Filing
History
2023-02-13
5:21 pm
Purchase
2022-12-3013GBiotech Acquisition Company
BIOT
GOLDMAN SACHS GROUP INC
GS
250,525
1.100%
250,525increase
(New Position)
Filing
History
2023-01-31
6:40 pm
Unchanged
2023-01-2713DCERo Therapeutics Holdings, Inc.
CERO
PHOENIX BIOTECH SPONSOR LLC2,648
78.200%
0
(Unchanged)
Filing
History
2023-01-25
07:24 am
Sale
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
HIGHBRIDGE CAPITAL MANAGEMENT LLC0
0.000%
-519decrease
(Position Closed)
Filing
History
Goto 0, 1, Next